Crescendo Biologics raises Series A led by Imperial Innovations

Crescendo Biologics has raised 17.5 million pounds ($28 million) in a Series A financing led by Imperial Innovations and including new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.

DealsNorth AmericaUSBriefs